Login

Financial Snapshot

Revenue
TTM
$415.6M
Gross Margin
TTM
90.94%
Net Income
TTM
-$2.376M
Current Assets
2026 Q1
Current Liabilities
2026 Q1
Current Ratio
2026 Q1
268.41%
Total Assets
2026 Q1
Total Liabilities
2026 Q1
Book Value
2026 Q1
$189.6M
Cash
2026 Q1
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
$16.92M

Stock Price

Loading...
Market Cap: $2.6005 Billion

About Arcutis Biotherapeutics Inc

Arcutis Biotherapeutics (NASDAQ: ARQT) is a biopharmaceutical company focused on developing and commercializing treatments for dermatological conditions. The filing excerpts provided do not contain sufficient detail to describe its revenue model, product portfolio, competitive position, financial results, leadership, or operating geography beyond the company's SEC registration identity. Based solely on the available filing content, no further factual claims about the business can be supported.

Source: SEC 10-K, filed 2026-02-25

Industry: Pharmaceutical Preparations Peers: Vericel Corp Avid Bioservices, Inc. Emergent BioSolutions Inc Enanta Pharmaceuticals Inc Kyntra Bio Inc Gossamer Bio Inc Kymera Therapeutics Inc Madrigal Pharmaceuticals Inc Sana Biotechnology Inc

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support